Malaria parasite carbonic anhydrase: inhibition of aromatic/heterocyclic sulfonamides and its therapeutic potential.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3609187)

Published in Asian Pac J Trop Biomed on June 01, 2011

Authors

Sudaratana R Krungkrai1, Jerapan Krungkrai

Author Affiliations

1: Unit of Biochemistry, Department of Medical Science, Faculty of Science, Rangsit University, Paholyothin Rd., Patumthani 12000, Thailand.

Articles cited by this

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47

Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89

WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet (2004) 9.27

Antimalarial drug resistance. J Clin Invest (2004) 8.50

Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med (2010) 7.22

Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature (2008) 5.96

Medical need, scientific opportunity and the drive for antimalarial drugs. Nature (2002) 4.73

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov (2008) 4.66

Biochemistry of Plasmodium (malarial parasites). Microbiol Rev (1979) 3.86

The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature (2008) 3.02

The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem (1971) 2.95

Structure and mechanism of carbonic anhydrase. Pharmacol Ther (1997) 2.85

Carbonic anhydrase: new insights for an ancient enzyme. J Biol Chem (2001) 2.17

Carbonic anhydrase inhibitors. Med Res Rev (2003) 2.09

Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discov (2005) 2.01

Mission possible. Nature (2007) 1.97

Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem (2004) 1.72

Structural and kinetic characterization of active-site histidine as a proton shuttle in catalysis by human carbonic anhydrase II. Biochemistry (2005) 1.69

GENETIC VARIATION AND EVOLUTION OF THE CARBOXYLIC ESTERASES AND CARBONIC ANHYDRASES OF PRIMATE ERYTHROCYTES. Am J Hum Genet (1965) 1.55

Drug-resistant malaria - an insight. FEBS J (2007) 1.54

Carbonic anhydrase is an ancient enzyme widespread in prokaryotes. Proc Natl Acad Sci U S A (1999) 1.46

Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem (2007) 1.45

Carbonic anhydrase IV and XIV knockout mice: roles of the respective carbonic anhydrases in buffering the extracellular space in brain. Proc Natl Acad Sci U S A (2005) 1.33

Chemical properties, distribution, and physiology of plant and algal carbonic anhydrases. Ann N Y Acad Sci (1984) 1.26

Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J Biol Chem (2003) 1.19

Epithelial carbonic anhydrases facilitate PCO2 and pH regulation in rat duodenal mucosa. J Physiol (2006) 1.17

Metal binding specificity in carbonic anhydrase is influenced by conserved hydrophobic core residues. Biochemistry (1999) 1.15

A role for iron in an ancient carbonic anhydrase. J Biol Chem (2003) 1.13

Sulfamates and their therapeutic potential. Med Res Rev (2005) 1.12

Carbonic anhydrase inhibitors. Bioorg Med Chem Lett (2010) 1.12

Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours. World J Gastroenterol (2005) 1.06

Human carbonic anhydrase XIV (CA14): cDNA cloning, mRNA expression, and mapping to chromosome 1. Genomics (1999) 1.02

Identification and characterization of a gene encoding a vertebrate-type carbonic anhydrase in cyanobacteria. J Bacteriol (1997) 1.00

Purification, characterization and localization of mitochondrial dihydroorotate dehydrogenase in Plasmodium falciparum, human malaria parasite. Biochim Biophys Acta (1995) 0.97

A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization. Biochemistry (2005) 0.95

Human malaria parasite orotate phosphoribosyltransferase: functional expression, characterization of kinetic reaction mechanism and inhibition profile. Mol Biochem Parasitol (2004) 0.95

A wheel invented three times. The molecular structures of the three carbonic anhydrases. EMBO Rep (2000) 0.93

Antimalarial activity of orotate analogs that inhibit dihydroorotase and dihydroorotate dehydrogenase. Biochem Pharmacol (1992) 0.93

Orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase exist as multienzyme complex in human malaria parasite Plasmodium falciparum. Biochem Biophys Res Commun (2004) 0.89

Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme. J Mol Biol (1994) 0.88

Carbonic anhydrase from Neisseria sicca, strain 6021. I. Bacterial growth and purification of the enzyme. Biochim Biophys Acta (1972) 0.88

The isolation and partial characterization of sulfonamide-resistant carbonic anhydrases from the liver of the male rat. Mol Pharmacol (1974) 0.86

Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies. Bioorg Med Chem Lett (2008) 0.86

Carbonic anhydrases as drug targets--an overview. Curr Top Med Chem (2007) 0.86

Pyrimidine biosynthesis in parasitic protozoa: purification of a monofunctional dihydroorotase from Plasmodium berghei and Crithidia fasciculata. Biochemistry (1990) 0.85

Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action? Bioorg Med Chem (2005) 0.85

Molecular biology and biochemistry of malarial parasite pyrimidine biosynthetic pathway. Southeast Asian J Trop Med Public Health (2003) 0.83

Characterisation of carbonic anhydrase in Plasmodium falciparum. Int J Parasitol (2001) 0.83

Bioinformatics analysis for structure and function of CPR of Plasmodium falciparum. Asian Pac J Trop Med (2011) 0.82

Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy. J Enzyme Inhib Med Chem (2004) 0.81

Structural basis for the decarboxylation of orotidine 5'-monophosphate (OMP) by Plasmodium falciparum OMP decarboxylase. J Biochem (2007) 0.81

The alpha-carbonic anhydrase from the malaria parasite and its inhibition. Curr Pharm Des (2008) 0.80

Dihydroorotase of human malarial parasite Plasmodium falciparum differs from host enzyme. Biochem Biophys Res Commun (2007) 0.79

External pH influences the transcriptional profile of the carbonic anhydrase, CAH-4b in Caenorhabditis elegans. Mol Biochem Parasitol (2008) 0.79

The pivotal role of carbonic anhydrase in malaria infection. Med Hypotheses (1998) 0.78

Malarial parasite carbonic anhydrase and its inhibitors. Curr Top Med Chem (2007) 0.77

Carbonic anhydrase from Neisseria sicca, strain 6021. II. Properties of the purified enzyme. Biochim Biophys Acta (1972) 0.77

Catalytic activity and inhibition of carbonic anhydrase of rat tissues. Biochem Pharmacol (1974) 0.76

Kinetic benefits and thermal stability of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase enzyme complex in human malaria parasite Plasmodium falciparum. Biochem Biophys Res Commun (2009) 0.76

Purification and characterization of dihydroorotate dehydrogenase from the rodent malaria parasite Plasmodium berghei. Biochemistry (1991) 0.76

Carbonic anhydrase of microorganisms. I. An enzyme from baker's yeast which catalyzes the formation of carbamate from ammonium bicarbonate solutions. Arch Biochem Biophys (1970) 0.76

Bioinformatics analysis and prediction for structure and function of nitric oxide synthase and similar proteins from Plasmodium berghei. Asian Pac J Trop Med (2011) 0.76

Crystallization and preliminary crystallographic analysis of orotidine 5'-monophosphate decarboxylase from the human malaria parasite Plasmodium falciparum. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.76

Articles by these authors

A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization. Biochemistry (2005) 0.95

Human malaria parasite orotate phosphoribosyltransferase: functional expression, characterization of kinetic reaction mechanism and inhibition profile. Mol Biochem Parasitol (2004) 0.95

Orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase exist as multienzyme complex in human malaria parasite Plasmodium falciparum. Biochem Biophys Res Commun (2004) 0.89

Structural basis for the decarboxylation of orotidine 5'-monophosphate (OMP) by Plasmodium falciparum OMP decarboxylase. J Biochem (2007) 0.81

Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy. J Enzyme Inhib Med Chem (2004) 0.81

Dihydroorotase of human malarial parasite Plasmodium falciparum differs from host enzyme. Biochem Biophys Res Commun (2007) 0.79

Crystallization and preliminary X-ray diffraction analysis of orotate phosphoribosyltransferase from the human malaria parasite Plasmodium falciparum. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.77

Kinetic benefits and thermal stability of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase enzyme complex in human malaria parasite Plasmodium falciparum. Biochem Biophys Res Commun (2009) 0.76

Crystallization and preliminary crystallographic analysis of orotidine 5'-monophosphate decarboxylase from the human malaria parasite Plasmodium falciparum. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.76

The in silico screening and X-ray structure analysis of the inhibitor complex of Plasmodium falciparum orotidine 5'-monophosphate decarboxylase. J Biochem (2012) 0.75